I n recent years, investigators studying hematopoietic stem cell (HSC) 3 engraftment have shifted their focus toward defining the behavior of these cells shortly after transplant. Although the long-term reconstituting activity of HSCs in murine transplant models has been well documented, there is an increasing interest in better understanding the activity of stem and progenitor cell populations at early times after infusion of a graft. The transition in interest from long-to short-term engraftment in HSC transplantation is partially the result of the need to promote rapid engraftment of functional blood cells in the first few weeks after clinical bone marrow (BM) transplantation. This has led investigators to begin to identify the BM cell populations that contribute to and facilitate early engraftment and to investigate the intrinsic and extrinsic factors that influence the kinetics of early engraftment after BM transplantation (1) (2) (3) (4) .
Studies comparing the kinetics of hematopoietic recovery after transplantation of enriched HSCs, as compared with unfractionated BM containing the same number of HSCs, have revealed a marked difference in reconstitutive capabilities of these two populations early after transplantation. In an analysis of the engraftment kinetics of whole BM containing 1000 Sca-1 ϩ Thy-1.1 low H-2K high cells transplanted into irradiated recipients, Szilvassy et al. (5) showed that the unfractionated cells produced a gradual but steady increase in leukocytes through day 30. However, the transplantation of 1000 isolated Sca-1 ϩ Thy-1.1 low H-2K high cells potentiated a sharp and transient increase in leukocyte counts 15 days after transplantation. Leukocyte counts then drastically diminished and eventually reached a normal range around day 30. These studies suggested that regulatory interactions between HSC and other BM cells are lost after cellular enrichment before transplantation, a conclusion that is also supported in studies of allogeneic transplants (6) .
Similar studies using a primitive subset of HSC selected based on low retention of the mitochondrial probe rhodamine-123 also demonstrated an early, temporary spike in PBMC counts after transplantation (7) . However, analysis of the cells comprising this recovery revealed that they were mainly monocytes and neutrophils and further showed that recovery of the B lymphoid lineage was not observed until about 30 days posttransplant. These results demonstrated that the HSC population within the BM is not capable of rapidly providing early lymphoid reconstitution. Transplantation of purified populations of actively cycling rhodamine-123 high multipotent progenitor cells or of the more lineage-restricted Sca-1 neg progenitor cells revealed that neither possessed the capacity to significantly regenerate leukocytes (7) (8) (9) . Thus, lymphocyte progenitor activity observed early after transplantation must be derived from an as yet uncharacterized progenitor cell population.
Interestingly, Okada et al. (10) reported the early recovery (14 -21 days) of myeloid and B lymphocytes in the blood after transplantation of highly enriched HSC that were selected based on expression of the c-kit molecule. This observation suggested that a cell population with different functional activities was isolated by this selection protocol compared with previous studies that had isolated HSC based on low levels of Thy-1.1 expression (11) . We report here a series of experiments aimed at testing this hypothesis and show that the addition of c-kit expression to the criteria used in previous studies to isolate HSC allows distinction of a committed progenitor population that predominantly generates B lineage cells within 2 wk of i.v. transplantation. By phenotype and function, these progenitors represent a cell population closely related to the common lymphoid progenitor (CLP) recently identified by Kondo et al. (12) . However, the lack of selection for the IL-7R in the present studies resulted in significant myeloid lineage potential as well as lymphoid potential in the isolated progenitor population. Interestingly, the use of different fluorochrome conjugates of the c-kit Ab led to variable results, suggesting that fluorochrome conjugates used to isolate particular cell populations can influence the in vivo reconstitutive capabilities of cells to which they bind.
Materials and Methods

Mice
BM donor animals were 4-to 8-wk-old B6-Thy-1.1-Ly-5.1 or B6.PL (Thy-1.1, Ly-5.2) congenic mice. C57BL/6 (Thy-1.2, Ly-5.2) or B6.SJL (Thy-1.2, Ly-5.1) mice between 8 and 10 wk old served as transplant recipients. Animals were bred and maintained at the Animal Resource Facility at the University of Utah (Salt Lake City, UT) or were purchased from The Jackson Laboratory (Bar Harbor, ME). All animals were maintained on autoclaved, acidified water (pH 2.5) and autoclaved chow.
Harvest and preparation of BM cells for cell sorting
BM was harvested from both femora and tibiae of donor mice. The bones were crushed with a mortar and pestle in HBSS containing 5% FCS and 10 mM HEPES buffer (HBSS/5). After filtering the cells through nylon mesh (pore size, 85 m; Small Parts, Miami Lakes, FL), cells were washed once with HBSS/5 and centrifuged (1200 rpm at 4°C) for 5 min. The resuspended pellet was treated with ammonium chloride-potassium solution for 2-3 min to lyse RBCs and then was washed again with HBSS/5. To remove mature blood cells from the BM and thereby enrich for rare stem and progenitor cell populations, BM cells were reacted with a lineage (Lin) cocktail containing optimized concentrations of eight mAbs. These mAbs recognize Ags associated with differentiated blood cells and include CD2 (RM-2.2), CD3 (KT3-1.1), CD5 (53-7.3), CD8 (53-6.7), Mac-1 (M1/70), TER-119 (an erythroid Ag), Gr-1 (RB6-8C5), and B220 (RA3-6B2). Cells were incubated with Lin cocktail at a cell density of 5 ϫ 10 7 cells/ml for 20 min. After the incubation period, cells were washed with HBSS/5 and subsequently incubated with sheep anti-rat Ig-coupled magnetic beads (Dynal, Oslo, Norway). The incubation was performed in a volume of 1 ml at a bead-to-cell ratio of 1:1 with intermittent mixing over a 20-min period. HBSS/5 was then added to bring the volume to 8 ml before magnetic depletion. This depletion process was repeated, and the remaining cells were then incubated with Ly-6A/E (Sca-1, clone D7) mAb conjugated to the fluorochrome PE (PharMingen, San Diego, CA) for 20 min on ice. After a wash, cells were resuspended in HBSS/5 containing 10 g/ml propidium iodide (PI; Molecular Probes, Eugene, OR) and filtered through nylon mesh.
Flow cytometry
Cells were sorted for Sca-1 ϩ PI neg cells using a FACS-Vantage instrument (Becton Dickinson, San Jose, CA) in enrich mode, using a threshold on PE staining as a trigger. Sorted cells were recovered by centrifugation and stained with anti-Thy-1.1 (clone 19XE5, conjugated in our laboratory to Oregon Green, Molecular Probes), PE-Sca-1, and one of two different antic-kit reagents. These were either a biotin conjugate (clone ACK4 (13) , kindly provided by S.-I. Nishikawa (Kyoto University, Kyoto, Japan) and biotinylated in our laboratory using standard techniques) or an allophycocyanin (APC) conjugate (clone 2B8; PharMingen). The biotin-c-kit reagent was detected with streptavidin-RED613 (Life Technologies, Gaithersburg, MD). After staining, the cells were washed and resuspended in HBSS/5 containing either To-Pro-2 (Molecular Probes) or PI for dead cell exclusion. Cell populations were then sorted using forward scatter triggering in normal recovery mode for Sca-1 ϩ c-kit ϩ cells, which were further segregated into Thy-1.1 neg and Thy-1.1 low subsets (Fig. 1) . Hereafter, the terms "Thy-1.1 neg " and "Thy-1.1 low " are used to indicate Lin neg populations that are coselected for the Sca-1 ϩ c-kit ϩ phenotype in addition to the presence or absence of Thy-1.1, as shown in Fig. 1 .
Two different c-kit reagents were utilized during the course of these studies (Fig. 1) . Although the APC-c-kit conjugate gave superior staining because of a higher signal, cell sorting experiments showed that the degree of engraftment was minimal when Thy-1.1 neg populations isolated using the APC-c-kit reagent were transplanted by the i.v. route. In contrast, the use of the biotin-c-kit conjugate for sorts resulted in reproducible recovery of transplantable lymphocyte progenitors in the Thy-1.1 neg population. Because in vitro culture assays did not demonstrate a difference in cloning efficiency or differentiation potential between cell populations isolated using the different Ab conjugates (data not shown), the engraftment defect of Thy-1.1 neg cells isolated using the APC reagent may be due to interference of in vivo homing by the bulky APC protein. Interestingly, Thy-1.1 low HSC preparations isolated using the two c-kit reagents were equally functional after in vivo transplants, suggesting that the inhibitory effect of the APCc-kit conjugate was specific for the Thy-1.1 neg progenitor cell population.
Transplantation of sorted cell populations
All recipient mice were exposed to 13 cGy of radiation from a 137 Cs source (Mark I gamma irradiator; J. L. Shepherd & Associates, Glendale, CA) delivered in two equal doses separated by a 3-h delay. Several hours later, mice were anesthetized using methoxyflurane and were administered purified cells in 0.2 ml HBSS/5 by retroorbital injection. Transplant recipients differed from donors at the Ly-5 locus. For competitive repopulation studies, transplants included 10 5 syngeneic BM cells in addition to purified congenic cells. Recipient animals were maintained on oral neomycin sulfate (Biosol, 2 mg/ml; Upjohn, Kalamazoo, MI) for 2 wk after irradiation and transplantation.
Analysis of transplant recipients
Engraftment was evaluated by immunofluorescent staining for the Ly-5 allelic Ag on PBMC, BM, and spleen cells at times ranging from 7 to 140 days after the transplants. For PBMC analysis, 150 l of blood was collected from the retroorbital sinus into a tube containing 20 l citrate dextrose anticoagulant (Formula A; Baxter Health Care, Mundelein, IL) using heparinized capillary tubes (Fisher Scientific, Pittsburgh, PA). A portion of each blood sample was removed to obtain complete blood counts using an automated hematology analyzer (Serono System 9010; Serono Diagnostics, Allentown, PA). The remainder of the blood was added to a volume of 2% Dextran T500 (Pharmacia Biotech, Piscataway, NJ) in PBS. This mixture was incubated for 30 min in a 37°C water bath to allow for sedimentation of RBCs. After incubation, the upper layer of PBMC was removed from each sample and centrifuged for 5 min at 1200 rpm. The pellet was resuspended in ammonium chloride-potassium solution to lyse residual RBCs and, after a wash in HBSS/5, each sample was aliquoted into three wells of a 96-well microtiter plate. The plate was then centrifuged for 2 min and decanted, and immunofluorescent staining was performed by reacting cells at a density of 5 ϫ 10 7 cells/ml with saturating solutions of mAb to define and phenotype donor-derived cells based on the allelic difference at the Ly-5 locus. T lymphocyte, B lymphocyte, and myeloid lineages of donor and recipient origin were measured using fluoresceinLy-5.1 staining in combination with CD4 and CD8 (T lineage), B220 (B lineage), or Mac-1 and Gr-1 (myeloid lineages) mAbs as PE conjugates. Animal groups were set up in duplicate so that no animal was bled more frequently than once per week.
BM and spleen tissues were isolated and single-cell suspensions were made as previously described (7). After RBC lysis, cell counts were determined and cells were reacted with mAb to define and phenotype cells of donor and recipient origin as described above. , and 0.1 mM 2-ME (Mallinckrodt Chemical, Chesterfield, MO). Myeloerythroid cultures (CFU-GM and CFU-Mix) were supplemented with the recombinant cytokines IL-3 (10 ng/ml; Peprotech, Rocky Hill, NJ), IL-6 (20 ng/ml; Peprotech), G-CSF (10 ng/ml; Amgen, Thousand Oaks, CA), and erythropoietin (5 U/ml; Ortho Pharmaceuticals, Raritan, NJ). For analysis of secondary CFU activity, lethally irradiated transplant recipients were euthanized 13 days after transplant of 10 3 cells, and BM was isolated.
Colony-forming assays
Secondary CFU activity was stimulated with IL-3, in the form of 20% WEHI-3B conditioned medium, plus recombinant human erythropoietin (5 U/ml; Ortho Pharmaceuticals). Cells were plated at two densities (5 ϫ 10 4 /ml and 5 ϫ 10 5 /ml) in 35-mm culture plates. All cultures were incubated at 37°C under 5% CO 2 , and colonies were enumerated 7-10 days later. CFU-Mix were identified as red colonies by visual inspection or after benzidine staining of hemoglobin. Cultures selective for growth of B lymphocyte progenitors (CFU-preB) contained steel factor (100 ng/ml, a kind gift from Kirin Pharmaceuticals, Tokyo, Japan), Flt3 ligand (75 ng/ml, kindly provided by Immunex, Seattle, WA), and IL-7 (10 ng/ml; Peprotech). Colonies were counted after 8 days.
Results
Definition of two subsets of c-kit ϩ hematopoietic progenitor cells
Previous studies have established that the Sca-1 Ag is expressed by virtually all HSC in the BM of adult B6 mice (8, 9) . Furthermore, HSC in adult mouse bone marrow express the Thy-1 Ag in an allele-specific manner, such that in mouse strains expressing Thy-1.1 but not Thy-1.2, HSC are entirely contained within the Thy-1 low subset of BM cells (14) . The tyrosine kinase receptor c-kit is a third Ag characteristic of mouse HSC (13) . However, the B lymphoid lineage has been reported to engraft within 2 weeks after transplantation of BM progenitors selected on the basis of dual expression of Sca-1 and c-kit (10) . In contrast, BM progenitors selected on the basis of Sca-1 and Thy-1.1 expression require 4 wk to regenerate B lymphocytes in the peripheral blood (7). To address this discrepancy, we evaluated the coexpression of Thy-1.1 and c-kit among Sca-1 ϩ Lin neg BM cells. As shown in Fig. 1 , c-kit ϩ Sca-1 ϩ Lin neg BM cells were subdivided into two populations of approximately equal frequency by Thy-1.1 staining. Furthermore, cells expressing Thy-1.1 appeared relatively homogeneous for a high level of c-kit expression, whereas those not expressing Thy-1.1 included both c-kit low and c-kit high subsets (Fig. 1B) . Although equivalent staining patterns and subset frequencies were observed with two different anti-c-kit reagents, an APC-conjugated reagent gave brighter staining and superior resolution of the different levels of c-kit expression compared with a biotin-conjugated reagent that was detected with streptavidin-RED613 (compare Fig. 1, A and B) . However, cells selected as c-kit ϩ Thy-1.1 neg using the APC conjugate consistently failed to engraft in irradiated recipient animals, whereas the same population selected using the biotin-avidin combination resulted in engraftment after transplantation. Interestingly, the engraftment defect observed when Thy-1.1 neg populations were selected using APC-c-kit was not observed when Thy-1.1 low c-kit high HSC were isolated in the same sorts and transplanted into irradiated recipients (data not shown). Consequently, in this paper we report only the transplant experiments performed using the avidin-biotin selection protocol.
Thy-1.1 neg and Thy-1.1 low cell populations differentially reconstitute blood lineages in irradiated animals
After transplantation of 5000 BM c-kit
neg cells, selected as either Thy-1.1 neg or Thy-1.1 low , into lethally irradiated recipient animals, we evaluated the recovery of peripheral blood cellularity over time (Fig. 2) . In both transplant groups, PBMC counts were below the level of detection (Ͻ0.2 ϫ 10 6 /ml) until 12 days after transplantation. Beginning at day 14, recipients of the Thy-1.1 neg subset exhibited highly variable PBMC counts, which in some cases exceeded the values observed in samples obtained from normal animals by severalfold ( Fig. 2A) . The variability in PBMC counts was to some extent due to the automated hematology counter detecting clumps of activated platelets or circulating normoblasts in the PBMC window, because flow cytometric analysis of the same samples showed few PBMC. In other cases, flow neg progenitors (F) or Thy-1.1 low HSC (E) into lethally irradiated recipient mice. The cell populations were enriched as shown in Fig. 1 , selecting for c-kit ϩ Sca-1 ϩ cells from lineage-depleted BM and separating these into two subsets based on expression of the Thy-1.1 Ag. The two cell populations were transplanted at a dose of 5000 cells per mouse, and cell counts were performed using a Serono hematology counter. No individual mouse was bled more frequently than once weekly. Data from three separate experiments were pooled and are depicted as mean counts Ϯ SEM. In some cases, error bars were too small to plot. cytometry confirmed high PBMC counts, and phenotypic analysis showed that the majority of circulating PBMC were of the B lymphoid lineage based on a B220
ϩ Mac-1/Gr-1 neg phenotype (Fig. 3,  A and B) . In contrast to recipients of Thy-1.1 neg cells, animals transplanted with Thy-1.1 low cells exhibited a gradual and very consistent increase in PBMC counts beginning at day 12 and reaching near-normal levels by day 30 ( Fig. 2A) . Phenotypic analysis demonstrated that the majority of cells appearing in the peripheral blood early after transplantation were of the myeloid lineage (Fig. 3, C and D) . In one representative experiment, groups of four animals transplanted with either Thy-1.1 neg or Thy-1.1 low cells were evaluated for the frequency of B lymphoid and myeloid cells in peripheral blood 14 days after transplantation. In recipients of Thy-1.1 neg grafts, donor-derived cells in the peripheral blood consisted of (mean Ϯ SD) 87.1 Ϯ 3.5% B lineage cells and 12.8 Ϯ 3.5% myeloid cells. In contrast, recipients of Thy-1.1 low HSC grafts included 16.3 Ϯ 6.8% B lineage cells and 83.3 Ϯ 6.9% myeloid cells among donor-derived peripheral blood cells. In the particular experiment from which the representative phenotypic analysis shown in Fig. 3 was derived, the average PBMC count at 14 days was 2-fold higher in recipients of Thy-1.1 neg cells compared with recipients of Thy-1.1 low cells (Fig. 2A) . In absolute numbers, the circulating B lineage cells ranged from 1.3 to 6.7 ϫ 10 6 cells/ml in recipients of Thy-1.1 neg grafts and from 0.1 to 0.4 ϫ 10 6 cells/ml in recipients of Thy-1.1 low grafts at day 14.
All
neg cells died of hematopoietic failure between days 25 and 30. The four surviving mice were observed in a single experiment in which contamination of the Thy-1.1 neg cell preparation with Thy-1.1 low HSC was apparent on reanalysis of the sorted cells; these animals are excluded from the data shown in Fig. 2 . The contamination of Thy-1.1 low cells in the Thy-1.1 neg population likely accounts for the survival of the animals, because even a 5% contamination among 5000 total cells will result in a sufficient number (250) of Thy-1.1 low HSC to mediate engraftment (11) . Therefore, the use of an optimized antiThy-1.1 reagent and rigorous flow cytometric separation with reanalysis of the two isolated cell populations was critical in separating progenitor cells from HSC for these experiments.
The absence of hematopoietic recovery in the erythroid and platelet lineages in recipients of Thy-1.1 neg grafts is shown in Fig.  2 , B and C. Suppression of both lineages was apparent in the first week after radiation conditioning, regardless of whether Thy-1.1 neg or Thy-1.1 low cells were transplanted. The earliest recovery of erythropoiesis after highly enriched HSC grafts has been reported to occur at about day 12 (5, 7), and the results shown in Fig.  2B are consistent with this finding. Irradiated recipients of Thy-1.1 low HSC exhibited prompt erythroid recovery that was maintained throughout the 60-day course of study with a mild degree of anemia. In contrast, animals transplanted with Thy-1.1 neg cells exhibited no erythroid recovery, and by 22 days, RBC counts were 3.33 Ϯ 0.95 ϫ 10 9 /ml (mean Ϯ SD; n ϭ 7) compared with the normal value of 9.79 Ϯ 0.7 ϫ 10 9 /ml (mean Ϯ SD; n ϭ 22). Platelet counts reached a deep nadir in both experimental groups 11 days posttransplant, but by 14 days, recipients of Thy-1.1 low HSC showed evidence of platelet engraftment and platelet counts were within the normal range (1.013 Ϯ 0.339 ϫ 10 9 /ml; mean Ϯ SD, n ϭ 22) by 26 days posttransplant. Recipients of Thy-1.1 neg cells exhibited no evidence of platelet engraftment before death (Fig. 2C) .
Differential BM engraftment by subsets of cells defined by Thy-1.1 expression
To test whether preferential engraftment of the B lymphocyte lineage by Thy-1.1 neg cells was due to the reconstitution of the BM with B lineage progenitors, we evaluated recovery of BM 13 days after transplantation of 10 3 purified cells. Although equivalent numbers of cells (5.5 ϫ 10 6 cells/femur) were recovered from transplant recipients of either Thy-1.1 low or Thy-1.1 neg cells, the phenotypic and functional composition of the BM was dramatically different. As shown in Fig. 4 , the frequencies of the lymphoid and myeloid components of BM obtained from recipients of Thy-1.1 low HSC closely resembled those observed in BM obtained from normal, untreated mice. In contrast, the balance between lymphoid and myeloid differentiation in the BM samples from recipients of Thy-1.1 neg progenitors was heavily skewed toward the lymphoid lineage, consisting largely of lymphoid cells and including very few cells expressing myeloid Ags (Fig. 4) . Consistent with this finding, spleens harvested from the recipient mice revealed 3.0 Ϯ 1.4 splenic colony-forming units (CFU-S) per 100 Thy-1.1 low cells transplanted but fewer than 0.2 CFU-S per 100 Thy-1.1 neg cells. Table I . Both subsets included a high frequency of myeloid progenitors compared with unfractionated BM. However, Thy-1.1 low HSC contained 4-fold more CFU-GM and 14-fold more CFU-Mix relative to Thy-1.1 neg progenitor cells. The frequency of CFU-preB was approximately equal in the two subsets and was enriched 700-to 1000-fold compared with normal BM (Table I) .
Primary and secondary colony-forming potential of
To evaluate the recovery of progenitors for the hematopoietic lineages after transplantation, secondary colony-forming assays were preformed. BM cells were isolated 13 days after transplants of 10 3 cells of each Thy-1.1 subset and were cultured in colony assays. As shown in Table I , BM obtained from recipients of Thy-1.1 low cells contained progenitor cells capable of growing in conditions supporting either myeloid or lymphoid differentiation. The frequency of colonies containing granulocytes and macrophages in the absence of erythroid development (CFU-GM) was similar to that observed in cultures of normal BM cells, and myeloid colonies containing erythroid differentiation (CFU-Mix) were also observed at a low frequency (4.5 CFU-Mix per 10 6 cells compared with 1.5 CFU-Mix per 10 4 cells in primary colony-forming assays). Colonies capable of growth under conditions supporting only B lymphoid progenitors (CFU-preB) were observed at a 10-fold lower frequency in cultures initiated from BM of Thy-1.1 low transplant recipients compared with normal BM. In contrast, the frequency of CFU-GM in cultures initiated from BM obtained from Thy-1.1 neg transplant recipients was 100-fold lower than that in control BM cultures, and no erythroid or lymphoid colonies were detected. Collectively, the results shown in Figs. 2-4 and Table I suggest that although the Thy-1.1 neg subset includes both myeloid and lymphoid progenitors, the cells capable of homing to the BM after i.v. transplantation are predominantly committed to differentiation along the lymphoid lineages and fail to regenerate significant numbers of additional progenitor cells.
T lineage progenitors are rare among Thy-1.1 neg cells and self-renewal is limited
The failure to observe CFU-preB in BM of mice transplanted with Thy-1.1 neg cells suggests that these cells reconstitute the B lineage progenitor compartment in the BM with non-self-renewing progenitors after transplantation. To further evaluate the potential of Thy-1. subsets to the platelet lineage was again clearly apparent in these experiments, despite the cotransplanted BM (Fig. 5A) . Compared with recipients of Thy-1.1 low cells, recipients of Thy-1.1 neg cells exhibited consistently lower platelet counts but equivalent PBMC counts throughout the 20-wk study period (Fig. 5B) . This is consistent with the data shown in Fig. 2 , indicating that Thy-1.1 low but not Thy-1.1 neg cells contribute to reconstitution of the platelet lineage. Therefore, the slow platelet recovery observed in recipients of Thy-1.1 neg cells in the competitive transplant assay (Fig. 5A ) is due solely to the cotransplanted syngeneic BM, whereas the more rapid platelet recovery seen after transplantation of Thy-1.1 low cells represents the aggregate contributions of both the cotransplanted BM and the Thy-1.1 low HSC. The relative contributions of b CFU-GM and CFU-Mix colonies were stimulated with steel factor, IL-3, IL-6, G-CSF, and erythropoietin. CFU-Mix colonies were defined by visible red coloring or by benzidine staining of hemoglobin. CFU-preB colonies were stimulated with steel factor, Flt3-ligand, and IL-7.
c BM harvested 13 days after transplantation of 10 3 Thy-1.1 low or Thy-1.1 neg cells into lethally irradiated recipients was cultured to determine colony-forming potential. Colony growth was scored after 7-10 days and is expressed as the mean Ϯ SEM of the number of colonies per 10 6 cells plated in each of four methylcellulose cultures. d CFU-GM and CFU-Mix colonies were stimulated using 20% WEHI-3B supernatant as a source of IL-3 and erythropoietin.
e Microcolonies; much smaller than typical CFU-GM. f No colonies detected in four cultures seeded with 5.6 ϫ 10 5 cells each.
purified cells vs cotransplanted BM to the platelet lineage were not directly assessed in these experiments because of the lack of Ly-5 expression by platelets. Contributions to the T lymphoid, B lymphoid, and myeloid lineages by Thy-1.1 neg and Thy-1.1 low cells are shown in Fig. 6 . In six of seven mice transplanted with Thy-1.1 neg cells, T lymphocytes were not observed above the threshold of detection (0.5% of PBMC, or 5 ϫ 10 3 cells/ml). One mouse of seven showed T cell engraftment, which reached a total of 2 ϫ 10 5 congenic T cells/ml by week 20. This animal also demonstrated about 2 ϫ 10 5 congenic myelocytes and B220 ϩ cells/ml in the peripheral blood. We have excluded this animal from the data shown in Fig. 6 because we cannot exclude the possibility of engraftment by a low level of contaminating Thy-1.1 low HSC contained in the Thy-1.1 neg cell preparation. Engraftment in this animal may also have been due to the presence of a minor subpopulation of Thy-1.1 neg cells capable of T cell development.
In contrast to the absence of T cell engraftment in the majority of recipients of Thy-1.1 neg cells, all animals transplanted with Thy-1.1 low HSC demonstrated robust, long-term T cell engraftment (Fig. 6A) . Animals in both transplant groups exhibited equivalent engraftment of the B lymphoid lineage at 4 wk posttransplant (Fig.  6B) . Although the absolute number of B220 ϩ cells in both transplant groups increased over the next 4 wk, the recipients of Thy-1.1 low HSC contained about 20-fold more of these cells per ml of blood at 8 wk compared with recipients of Thy-1.1 neg progenitors. Between 8 and 20 wk posttransplant, the number of B lineage cells continued to increase in Thy-1.1 low recipients but declined in recipients of Thy-1.1 neg cells. Myeloid engraftment was high at all times posttransplant of Thy-1.1 low HSC but was represented at 50-to 100-fold lower levels in recipients of Thy-1.1 neg progenitors (Fig. 6C) .
Discussion
Although a variety of studies have documented commitment to the B lymphoid lineage and have traced lineage relationships based on expression patterns of cell surface molecules (15, 16) , relatively few studies have shown activity of committed B lineage progenitors in transplant experiments (17, 18) . Due to the high degree of proliferative potential inherent in uncommitted hematopoietic stem cells, clonal transplant assays can be utilized to demonstrate multilineage engraftment in vivo from single cells (19 -21) . In contrast, lineage-specific progenitor cells lack extensive proliferative potential (22) . Because of this, lineage-restricted reconstituting activity of hematopoietic progenitor cells has been difficult to demonstrate in transplant models.
A critical consideration in experiments such as those reported in this study is that putative progenitor populations must be isolated in the absence of HSC to demonstrate lineage restriction in nonclonal models. The high proliferative potential of HSC will lead to long-term reconstitution even when a low level of stem cell contamination is present. If early commitment events lead to a restricted representation of lineages in a clone derived from a HSC, the results can be erroneously interpreted as engraftment of a lineage-restricted progenitor. Immunodeficient mouse strains such as severe combined immunodeficiency mutants or recombinase knockouts have been exploited as animal models permissive for lymphoid engraftment in transplant experiments (12, 23, 24) . However, the use of immunodeficient mouse strains as transplant recipients may preferentially select for lymphoid engraftment because the nonlymphoid lineages in these animals are normal. This may lead to underestimates of the myeloid and erythroid potentials of transplanted cell populations. In support of this concept, immunodeficient patients who are treated with allogeneic bone marrow transplants often demonstrate mixed chimerism that results in donor-derived lymphoid but not myeloid reconstitution (25, 26) . These considerations must be taken into account in transplant studies using early hematopoietic progenitors.
The studies reported in this paper document a transplantable progenitor with restricted lineage potential. The cell population described in these studies has a pattern of surface Ag expression that is very similar to that of HSC, with the exception being a difference in expression of Thy-1.1. Elsewhere we have shown that mouse HSC invariably express Thy-1.1 (14) , and it is this lack of HSC contamination among Thy-1.1 neg cells that results in the ability to completely separate the lymphoid progenitor population from multipotent HSC. This separation will not work in mouse strains expressing the Thy-1.2 allele because about 50% of the HSC in these strains lack Thy-1 expression. Contamination of Thy-1.1 neg cell preparations by Thy-1.1 low HSC was noted by sort reanalysis and by functional studies in some of our experiments, underscoring the importance of carefully controlled cell sorting techniques in hematopoietic progenitor separations.
The Thy-1.1 neg progenitor cell population we have characterized largely overlaps with a CLP cell subset previously isolated on the basis of expression of IL-7R (12) . In those studies, CLP were selected by a Lin neg phenotype in combination with low levels of c-kit and Sca-1 expression as well as IL-7R expression. The majority of these cells, which comprised 0.02% of BM, lacked expression of Thy-1.1. The selection described herein utilizes selection for Thy-1.1, Sca-1, and c-kit expression among Lin neg cells but does not include discrimination based on IL-7R and thus selects a larger population of cells (0.1% of total BM). It is likely that the lack of selection for IL-7R in the present studies resulted in the recovery of myeloid progenitors in addition to lymphoid progenitors because IL-7R expression is limited to the lymphoid lineage. Interestingly, the presence of a significant number of myeloid progenitors among Thy-1.1 neg cells (Table I) did not result in measurable engraftment of platelets, RBCs, or myelomonocytic cells in transplant experiments (Figs. 2, 4, and 6 ). This may be due to a relative lack of proliferation potential in early myelopoiesis compared with the significant expansion that occurs at the pro-B stage of development. Alternatively, the myeloid progenitors present in the Thy-1.1 neg subset may lack the ability to home to the BM and establish myelopoiesis (Fig. 4) . These studies support the concept of an early separation between erythroid and platelet lineages from other myeloid progenitors because these lineages were not observed to recover after transplantation of Thy-1.1 neg cells (Fig. 2 ) and because erythroid colonies were rarely observed in cultures (Table I) . Evidence of a separation of erythroid and platelet progenitors from other myeloid lineages early in hematopoietic development has recently been demonstrated in cell enrichment studies (27) . Kondo et al. (12) utilized clonal analysis to demonstrate that clones generated from single CLP included both T and B lineage potential. However, T lineage potential was evaluated by direct intrathymic injection of individual clones. The low frequency of T cell potential in the Thy-1.1 neg subset isolated in our studies may indicate a defect in thymic homing because our i.v. transplant assay requires both homing, intrathymic proliferation and export of a sufficient number of mature T lymphocytes for detection in the peripheral blood. However, the relevant BM progenitor for T cells is also required to perform these functions to maintain the peripheral pool of T lymphocytes. Therefore, our studies suggest that the cell population that normally seeds the thymus may be a minor subpopulation of the Thy-1.1 neg BM subset, despite the ability of freshly isolated cells or clones derived from those cells to differentiate along the T lineage when injected into the thymus (12) . This interpretation is supported by a recent study that shows that B lineage progenitors isolated from Pax5 knockout animals can be reprogrammed to differentiate into multiple hematopoietic lineages, including the T cell lineage (28) . It is possible that the in vitro culture utilized by Kondo et al. (12) induced such a lineage reprogramming process in cells that are normally committed to the B lymphoid lineage. Alternatively, segregation of the Thy-1.1 neg population using additional Ags may reveal a small subset with T lineage potential that was transplanted at a frequency too low to be detected in the present studies.
The robust reconstitution of BM and peripheral blood B lineage cells but not other hematopoietic lineages by Thy-1.1 neg cells suggests that this cell population predominantly includes progenitors committed to the B lineage. In separate studies, we have used cell separation techniques and in vitro cultures to show that over 50% of the cells contained in the Thy-1.1 neg subset are committed myeloid progenitors that can be separated from the lymphoid progenitors based on levels of c-kit expression. 4 Interestingly, myeloid engraftment was minimal in the studies reported in this paper (Figs. 3, 4, and 6 ), despite the presence of many myeloid progenitors in the transplanted Thy-1.1 neg population (Table I) . This suggests that the homing or proliferation of the myeloid progenitor cells contained within the Thy-1.1 neg subset is insufficient to result in significant engraftment. Alternatively, the progeny of the myeloid progenitors may be rapidly sequestered in tissues or may have too short of a lifespan to be detected at the time we evaluated engraftment posttransplant. We assume that the minor degree of myeloid engraftment observed in the present studies (Figs. 3, 4 , and 6) was due to the myeloid progenitors contained within the Thy-1.1 neg cell population. Bauman et al. (29) reported effects of specific Ab detection systems on hematopoietic engraftment analogous to those observed in our studies. In those studies, it was shown that anti-class I MHC Abs detected using an anti-rat secondary reagent inhibited CFU-S activity, whereas anti-class I MHC Abs conjugated to biotin did not have this inhibitory effect. The group concluded that the reduction in CFU-S numbers was due to the phagocytosis of cells opsonized with anti-rat Abs. This did not occur in the case of staining with the avidin-fluorochrome conjugate, possibly because of the presence of fewer Fc regions or because of masking of Fc determinants by the biotin-avidin complexes, which prevented recognition and subsequent phagocytosis of these cells by macrophages. In our studies, a similar mechanism may be causing the preferential removal of cells bound to APC-conjugated Abs. Such a response may be stimulated by the large size and foreign nature of APC (derived from algae), which could activate macrophages to phagocytose Thy-1.1 neg cells opsonized with APC-labeled Abs in a manner similar to that described by Bauman et al. (29) . However, the lack of an inhibitory effect of the APC-conjugated c-kit reagent on transplantation of Thy-1.1 low cells, which express very high levels of c-kit (Fig. 1) , makes this interpretation difficult to justify. Additional experiments will be required to resolve this question.
The clear clinical value of the Thy1.1 neg cell population in mediating early, albeit transient, PBMC recovery in the posttransplant setting makes it important for us to define the mechanisms that regulate engraftment of this cell population and its ability to facilitate lymphoid reconstitution. In addition, as transplant products are increasingly subjected to in vitro manipulations before infusion to engineer specific balances of graft-vs-leukemia effects with hematopoietic engraftment (30, 31) , it will be increasingly important to clarify biologic effects of Ab staining on subsequent transplantation potential.
